Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...

Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.

2025 Q3 Financial Results (as of September 30, 2025) ...

EQS-News: ABIVAX / Key word (s): Miscellaneous Abivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.

A new study has shown more than 90% accuracy in predicting bowel cancer risk, based on a high-risk group of people living ...

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new ... with moderately-to-severely active UC, a fourth indication for the ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in ... as a treatment for moderately to severely active UC, a few weeks after it was cleared by the European Commission.

Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...

Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Shares of ABIVAX Société Anonyme (NASDAQ:ABVX – Get Free Report) have been assigned a consensus rating of “Buy” from the ...